Document Detail

Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1 ) receptor in assays for antidepressant and anxiolytic drugs.
MedLine Citation:
PMID:  11742144     Owner:  NLM     Status:  MEDLINE    
The phenotype of NK1R-/- mice was compared with that of acute pharmacological blockade of the tachykinin NK1 receptor on sensorimotor function and in assays relevant to depressive illness and anxiety. The dose range for L-760735 and GR205171 that was associated with functional blockade of central NK1 receptors in the target species was established by antagonism of the behavioural effects of intracerebroventricular NK1 agonist challenge in gerbils, mice and rats. The caudal grooming and scratching response to GR73632 was absent in NK1R-/- mice, confirming that the receptor had been genetically ablated. There was no evidence of sedation or motor impairment in NK1R-/- mice or following administration of L-760735 to gerbils, even at doses in excess of those required for central NK1 receptor occupancy. In the resident-intruder and forced swim test, the behaviour of NK1R-/- mice, or animals treated acutely with L-760735 or GR205171, resembled that seen with the clinically used antidepressant drug fluoxetine. However, the effects of GR205171 were not clearly enantioselective in mice. In contrast, although NK1R-/- mice also exhibited an increase in the duration of struggle behaviour in the tail suspension test, this was not observed following pharmacological blockade with L-760735 in gerbils or GR205171 in mice, suggesting that this may reflect a developmental alteration in the knockout mouse. There was no effect of NK1 receptor blockade with L-760735 in guinea-pigs or GR205171 in rats, or deletion of the NK1 receptor in mice, on behaviour in the elevated plus-maze test for anxiolytic activity. These findings extend previous observations on the phenotype of the NK1R-/- mouse and establish a broadly similar profile following acute pharmacological blockade of the receptor. These studies also serve to underscore the limitations of currently available antagonists that are suitable for use in rat and mouse behavioural assays.
N M Rupniak; E J Carlson; J K Webb; T Harrison; R D Porsolt; S Roux; C de Felipe; S P Hunt; B Oates; A Wheeldon
Related Documents :
22434934 - Cannabinoids induce pancreatic β-cell death by directly inhibiting insulin receptor act...
22821234 - Design and functional characterization of a novel, arrestin-biased designer g protein-c...
22778874 - Cross-receptor interactions between dopamine d(2l) and neurotensin nts(1) receptors mod...
11698044 - Airway inflammation and tachykinins: prospects for the development of tachykinin recept...
16918764 - Altered tachykinergic influence on gastric mechanical activity in mdx mice.
2160004 - Cyclazocine and pentazocine as n-methylaspartate antagonists on cat and rat spinal neur...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Behavioural pharmacology     Volume:  12     ISSN:  0955-8810     ISO Abbreviation:  Behav Pharmacol     Publication Date:  2001 Nov 
Date Detail:
Created Date:  2001-12-19     Completed Date:  2002-03-20     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  9013016     Medline TA:  Behav Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  497-508     Citation Subset:  IM    
Merck Sharp and Dohme Neuroscience Research Centre, Harlow, Essex, CM20 2QR, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-Anxiety Agents / pharmacology*
Antidepressive Agents / pharmacology*
Anxiety / genetics*
Arousal / drug effects,  genetics*
Brain / drug effects
Depression / genetics*
Dose-Response Relationship, Drug
Guinea Pigs
Helplessness, Learned
Morpholines / pharmacology
Mutation / genetics*
Piperidines / pharmacology
Rats, Sprague-Dawley
Receptors, Neurokinin-1 / antagonists & inhibitors,  genetics*
Species Specificity
Tetrazoles / pharmacology
Reg. No./Substance:
0/Anti-Anxiety Agents; 0/Antidepressive Agents; 0/L 760735; 0/Morpholines; 0/Piperidines; 0/Receptors, Neurokinin-1; 0/Tetrazoles; K08BK043YS/vofopitant

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  DRL performance in mice with deletion of tPA, uPA or PAI-1 genes.
Next Document:  Acoustic startle, conditioned startle potentiation and the effects of 8-OH-DPAT and buspirone in rat...